Human African trypanosomiasis
Top Cited Papers
- 14 October 2009
- journal article
- seminar
- Published by Elsevier BV in The Lancet
- Vol. 375 (9709), 148-159
- https://doi.org/10.1016/s0140-6736(09)60829-1
Abstract
No abstract availableThis publication has 116 references indexed in Scilit:
- Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trialThe Lancet, 2009
- Enantioselective and Nonlinear Intestinal Absorption of Eflornithine in the RatAntimicrobial Agents and Chemotherapy, 2008
- Kinetoplastids: related protozoan pathogens, different diseasesJCI Insight, 2008
- Safety and effectiveness of first line eflornithine for Trypanosoma brucei gambiense sleeping sickness in Sudan: cohort studyBMJ, 2008
- Human African trypanosomiasis: pharmacological re‐engagement with a neglected diseaseBritish Journal of Pharmacology, 2007
- Analysis of the VSG gene silent archive in Trypanosoma brucei reveals that mosaic gene expression is prominent in antigenic variation and is favored by archive substructureGenome Research, 2007
- Switching trypanosome coats: what's in the wardrobe?Trends in Genetics, 2006
- Molecular Dipstick Test for Diagnosis of Sleeping SicknessJournal of Clinical Microbiology, 2006
- Diagnosing human African trypanosomiasis in Angola using a card agglutination test: observational study of active and passive case finding strategiesBMJ, 2006
- Sleeping sickness in Uganda: a thin line between two fatal diseasesBMJ, 2005